Terms: = Endocrine gland cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
266 results:
1. Long non-coding RNA
Wei Y; Zhu P
Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
[TBL] [Abstract] [Full Text] [Related]
2. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
[TBL] [Abstract] [Full Text] [Related]
3. Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Arakawa Y; Jo U; Kumar S; Sun NY; Elloumi F; Thomas A; Roper N; Varghese DG; Takebe N; Zhang X; Ceribelli M; Holland DO; Beck E; Itkin Z; McKnight C; Wilson KM; Travers J; Klumpp-Thomas C; Thomas CJ; Hoang CD; Hernandez JM; Del Rivero J; Pommier Y
Cancer Res Commun; 2024 Mar; 4(3):834-848. PubMed ID: 38451783
[TBL] [Abstract] [Full Text] [Related]
4. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
[TBL] [Abstract] [Full Text] [Related]
5. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway.
Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
[TBL] [Abstract] [Full Text] [Related]
6. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive Long-Read Sequencing Analysis Discloses the Transcriptome Features of Papillary Thyroid Microcarcinoma.
Wang Y; Zou B; Zhang Y; Zhang J; Li S; Yu B; An Z; Li L; Cui S; Zhang Y; Yao J; Shi X; Liu J
J Clin Endocrinol Metab; 2024 Apr; 109(5):1263-1274. PubMed ID: 38038628
[TBL] [Abstract] [Full Text] [Related]
8. CUDC-907 exhibits potent antitumor effects against ovarian cancer through multiple in vivo and in vitro mechanisms.
Wang Y; Wen J; Sun X; Sun Y; Liu Y; Cheng X; Wu W; Liu Q; Ren F
Cancer Chemother Pharmacol; 2024 Apr; 93(4):295-306. PubMed ID: 37938423
[TBL] [Abstract] [Full Text] [Related]
9. Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines.
Masuo H; Kubota K; Shimizu A; Notake T; Miyazaki S; Yoshizawa T; Sakai H; Hayashi H; Soejima Y
Cancer Sci; 2023 Nov; 114(11):4388-4400. PubMed ID: 37700464
[TBL] [Abstract] [Full Text] [Related]
10. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
[TBL] [Abstract] [Full Text] [Related]
11. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
[TBL] [Abstract] [Full Text] [Related]
12. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
[TBL] [Abstract] [Full Text] [Related]
14. PD-L1 and MCL-1 markers and the relationship with prognostic characteristics of differentiated thyroid carcinoma.
Zantut-Wittmann DE; Barreto IS; Laus AC; Moreno DA; Moma CA; Maia FFR; Assumpção LVMD; Reis RM
Mol Cell Endocrinol; 2023 Jun; 570():111931. PubMed ID: 37072108
[TBL] [Abstract] [Full Text] [Related]
15. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
16. Dihydrotanshinone I Inhibits Pancreatic cancer Progression
Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
[TBL] [Abstract] [Full Text] [Related]
17. Validation of a New Prognostic Score in Patients with Ovarian Adenocarcinoma.
Trifanescu OG; Mitrica RI; Gales LN; Marinescu SA; Motas N; Trifanescu RA; Rebegea L; Gherghe M; Georgescu DE; Serbanescu GL; Bashar HH; Dragosloveanu S; Cristian DA; Anghel RM
Medicina (Kaunas); 2023 Jan; 59(2):. PubMed ID: 36837431
[No Abstract] [Full Text] [Related]
18. In Vitro Anticancer Activity of Novel Ciprofloxacin Mannich Base in Lung Adenocarcinoma and High-Grade Serous Ovarian cancer Cell Lines via Attenuating MAPK Signaling Pathway.
Fawzy MA; Abu-Baih RH; Abuo-Rahma GEA; Abdel-Rahman IM; El-Sheikh AAK; Nazmy MH
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770806
[TBL] [Abstract] [Full Text] [Related]
19. Splicing factor BUD31 promotes ovarian cancer progression through sustaining the expression of anti-apoptotic bcl2L12.
Wang Z; Wang S; Qin J; Zhang X; Lu G; Liu H; Guo H; Wu L; Shender VO; Shao C; Kong B; Liu Z
Nat Commun; 2022 Oct; 13(1):6246. PubMed ID: 36271053
[TBL] [Abstract] [Full Text] [Related]
20. Tongguanteng injection reverses paclitaxel resistance via upregulation of TAB1 expression in ovarian cancer in vitro and in vivo.
Kong QW; Yang J; Li D; Ding YW; Hu YJ; Xue XC; Shi MZ; Jiang B; Zhou YY; Zhang M; Hu JD; Guo C; Chen JJ; Han YL
J Ethnopharmacol; 2023 Jan; 300():115728. PubMed ID: 36126783
[TBL] [Abstract] [Full Text] [Related]
[Next]
